Malaria

Adjunctive therapy for Malaria: Aspirin, an anti-inflammatory drug used in the treatment of fever, pain, and others, increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 16/April/2018, 10.31 am

Adjunctive therapy for Malaria: Aspirin, an anti-inflammatory drug used in the treatment of fever, pain, and others, increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 16/April/2018, 10.31 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Section on Human Iron Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD…

read more

Amino sugar-based therapy for blood-stage Plasmodium infection: D-Glucosamine (GlcN), an amino sugar, decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 10/April/2018, 7.28 pm

Amino sugar-based therapy for blood-stage Plasmodium infection: D-Glucosamine (GlcN), an amino sugar, decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 10/April/2018, 7.28 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

read more

Natural product-based therapy for blood-stage Plasmodium infection: Moringin, isolated from moringa olifera, decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 10/April/2018, 6.29 pm

Natural product-based therapy for blood-stage Plasmodium infection: Moringin, isolated from moringa olifera, decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 10/April/2018, 6.29 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

read more

Small molecule-based therapy for Malaria: N-Acetyl Cysteine (NAC) increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 7/April/2018, 10.36 pm

Small molecule-based therapy for Malaria: N-Acetyl Cysteine (NAC) increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 7/April/2018, 10.36 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Section on Human Iron Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD…

read more

Natural product-derived therapy for Malaria: β-Cryptoxanthin(BCX), found abundantly in Satsuma mandarin, among others,  increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 5/April/2018, 1.40 am

Natural product-derived therapy for Malaria: β-Cryptoxanthin(BCX), found abundantly in Satsuma mandarin, among others,  increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 5/April/2018, 1.40 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Section on Human Iron Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD…

read more

Natural product-derived therapy for Malaria:  Nordihydroguaiaretic acid, isolated from Larrea tridentate,  increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 4/April/2018, 12.50 am

Natural product-derived therapy for Malaria:  Nordihydroguaiaretic acid, isolated from Larrea tridentate,  increases Ferroportin expression, decreases intracellular iron accumulation, inhibits cellular damage, prevents hemolysis, and inhibits malaria infection, via upregulation of its target gene, 4/April/2018, 12.50 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Section on Human Iron Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD…

read more